Rene-Marc Flipo
Overview
Explore the profile of Rene-Marc Flipo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
2239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Darrieutort-Laffite C, Coiffier G, Aim F, Banal F, Bart G, Chazerain P, et al.
Joint Bone Spine
. 2023 Nov;
91(2):105664.
PMID: 37995861
Septic bursitis (SB) is a common condition accounting for one third of all cases of inflammatory bursitis. It is often related to professional activities. Management is heterogeneous and either ambulatory...
12.
Govoni M, Batalov A, Boumpas D, DAngelo S, De Keyser F, Flipo R, et al.
Clin Exp Rheumatol
. 2023 Nov;
42(3):642-650.
PMID: 37976120
Objectives: Rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) patients often experience secondary non-response to a first-line tumour necrosis factor alpha inhibitor (TNFαi). This pooled analysis of six...
13.
Philippoteaux C, Marty-Ane A, Cailliau E, Labreuche J, Philippe P, Cortet B, et al.
Semin Arthritis Rheum
. 2023 Oct;
63:152275.
PMID: 37852155
Objective: The EULAR task force recently published the difficult-to-treat rheumatoid arthritis (D2T RA) criteria, however, a definition of D2T patients in psoriatic arthritis (PsA) is still lacking. To date, we...
14.
Nguyen Y, Mariette X, Gottenberg J, Iudici M, Morel J, Vittecoq O, et al.
Rheumatology (Oxford)
. 2023 Sep;
63(7):1893-1901.
PMID: 37725356
Objectives: To investigate whether the efficacy and safety data from drug-registration trials can be extrapolated to real-life RA patients receiving RTX. Methods: The 'AutoImmunity and Rituximab' (AIR-PR) registry is a...
15.
Assaraf M, Chevet B, Wendling D, Philippe P, Cailliau E, Roux C, et al.
Rheumatology (Oxford)
. 2023 Aug;
63(8):2065-2073.
PMID: 37603729
Objectives: The efficacy of anti-IL-6 receptors such as tocilizumab (TCZ) was demonstrated in patients with PMR in two recent randomized controlled trials. The objective of this multicentre retrospective study was...
16.
Perrot L, Boyer L, Flipo R, Marotte H, Pertuiset E, Miceli C, et al.
Joint Bone Spine
. 2023 Jul;
90(6):105608.
PMID: 37414137
Objectives: The objective of the current study was to evaluate the severity of COVID-19 and identify factors associated with severe disease outcomes in patients with spondyloarthritis (SpA), a chronic inflammatory...
17.
Drumez E, Richez C, Bebear L, Herasse M, Flipo R, Marotte H, et al.
Joint Bone Spine
. 2023 Jul;
90(5):105605.
PMID: 37399939
No abstract available.
18.
Desvages A, Hives F, Deprez X, Pierache A, Behal H, Flipo R, et al.
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109181
Introduction: We aimed to evaluate the utility of FDG-PET/CT in diagnosing polymyalgia rheumatica (PMR) and associated large-vessel vasculitis (LVV). Methods: We analyzed FDG-PET/CT completed between 2015 and 2019 on patients...
19.
Chevalier K, Genin M, Jean T, Avouac J, Flipo R, Georgin-Lavialle S, et al.
Front Med (Lausanne)
. 2023 Apr;
10:1152587.
PMID: 37035330
Introduction: Autoimmune/inflammatory rheumatic diseases (AIRDs) patients might be at-risk of severe COVID-19. However, whether this is linked to the disease or to its treatment is difficult to determine. This study...
20.
Comarmond C, Drumez E, Labreuche J, Hachulla E, Thomas T, Flipo R, et al.
J Transl Autoimmun
. 2023 Jan;
6:100190.
PMID: 36684808
Objective: COVID-19 outcome may be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases (RMD) receiving immunosuppressive therapy. We aimed to investigate whether RMD patients on anti-IL6 therapy prior...